STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT00088088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Trial of STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is for patients who have Stage IIIb or Stage IV NSCLC and have never had chemotherapy before for their disease. The first phase of the study recently completed and for the second phase of the study patients are randomly assigned to receive either paclitaxel and carboplatin or paclitaxel and carboplatin and study drug (STA 4783). Treatment will be every 3 weeks for 6 cycles.
Study identification
- NCT ID
- NCT00088088
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 86 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Not listed
- Completion
- Feb 28, 2005
- Last update posted
- Dec 3, 2008
2004 – 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NEA Clinic | Jonesboro | Arkansas | 72401 | — |
| Wilshire Oncology Medical Group | Pomona | California | 91767 | — |
| St. Francis Memorial Hospital | San Francisco | California | — | — |
| Cancer Institute Medical Group | Santa Monica | California | 90404 | — |
| Kaiser Permanete | Vallejo | California | — | — |
| Oncology Associates of Bridgeport | Trumball | Connecticut | 06611 | — |
| ACORN | Miami | Florida | — | — |
| Oncology Hematology Consultants | Sarasota | Florida | 34236 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| The Cancer Institute at Alexian Brothers | Elk Grove Village | Illinois | 60007 | — |
| Ingalls Hospital | Harvey | Illinois | 60426 | — |
| Overton Brooks, VAMC | Shreveport | Louisiana | 71101 | — |
| LSUHSC - Shreveport Feist Weiller Cancer Center | Shreveport | Louisiana | 71130 | — |
| Maryland Hematology and Oncology Associates | Baltimore | Maryland | 21236 | — |
| The Duluth Clinic | Duluth | Minnesota | 55805 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| The Sarah Cannon Research Center | Nashville | Tennessee | 37203 | — |
| Presbyterian Hospital | Dallas | Texas | 75231 | — |
| Multicare Health System | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2008 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00088088 live on ClinicalTrials.gov.